Reducing Risk in Drug Candidate Selection and Development

Among the myriad of questions to consider in designating a compound a “lead drug candidate,” one of the most overlooked is the question of “druggability.” Druggability refers to the physical and chemical stability of the molecule and the ability to manufacture the compound as a drug substance and as a formulated drug product. Alongside intellectual property, market size and efficacy, druggability is critical to the long term success of a compound in development. Biocom has organized this event to explore the meaning and ramifications of druggability. More information and online registration is here.